TABLE 2.
Base Case Cost-effectiveness of Strategies for Increasing HPV Vaccination
| Approach | Cost, $ | Additional Individuals Vaccinated, n | Incremental Vaccination, n | Cost per Additional Person Vaccinated, $ | Cancers Averted, n | Incremental Cancers Averted, n | Cost per HPV Cancer Averted, $ | QALYs Gained, n | Incremental QALYs Gained, n | Cost per QALY Gained, $ | Cost per QALY Gained Versus No Intervention, $ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| QI visits | 64 855 | 3733 | 3733 | 17 | 44 | 44 | 1475 | 42 | 42 | 1538 | 1538 |
| Reminder and recall | 984 270 | 6993 | 3260 | 282 | 76 | 32 | 28 333 | 75 | 33 | 28 290a | 13 183 |
| School-located vaccination | 3 038 752 | 18 721 | 14 988a | 198a | 212 | 168a | 17 691a | 204 | 162a | 18 337a | 14 871 |
QALYs are discounted at 3% per year.
a
Indicates that school-located vaccination has extended dominance compared with reminder and recall intervention; comparisons were made to QI visits instead.